Articles
Brolucizumab Gets FDA Approval for Wet AMD
For most patients, 3-month dosing is achievable.
Complications After Removal of Silicone Oil
Droplets can migrate and cause damage to intraocular structures.
In Situ Retinal Regeneration
Promoting the health, maintenance, and regeneration of retinal cells with norrin.
Laser Therapy vs Anti-VEGF for Diabetic Retinopathy
Patient compliance is a key factor in treatment choice.
An Introduction to MIGS for the Retina Specialist
Considerations for managing patients with new glaucoma devices and surgeries.
Tips for Anterior-Segment Manipulation
Attention to detail can maximize surgical outcomes.
CLINICAL TRIAL DOWNLOAD: Safety Data on KSI-301 Antibody Biopolymer Conjugate for Retinal Disease
Retina specialists discuss phase 1b data for a drug with potential for quarterly or longer administration.
CODING Q&A: Global Confusion
Billing for a procedure done during the global period of a prior procedure.
NEW PRODUCT APPLICATIONS: A Dual-Blade Probe to Enhance Vitrectomy Efficiency
Smaller gauge sizes can perform higher cut rates.
Management of Blepharitis and Conjunctivitis Before Intravitreal Injection or Retinal Surgery
Recognition, treatment, and counseling improve patient experience.
On the Horizon
This new column is designed to highlight new and innovative early stage and preclinical concepts that could one day help to advance the everyday practice of retina specialists